+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy

Experimental and Molecular Medicine 41(11): 802-811

Advanced glycation endproducts (AGEs)-induced vascular smooth muscle cell (VSMCs) proliferation and formation of reactive oxygen species (ROS) are emerging as one of the important mechanisms of diabetic vasculopathy but little is known about the antioxidative action of HMG CoA reductase inhibitor (statin) on AGEs. We hypothesized that statin might reduce AGEs-induced intracellular ROS of VSMCs and analyzed the possible mechanism of action of statin in AGEs-induced cellular signaling. Aortic smooth muscle cell of Sprague-Dawley rat (RASMC) culture was done using the different levels of AGEs stimulation in the presence or absence of statin. The proliferation of RASMC, ROS formation and cellular signaling was evaluated and neointimal formation after balloon injury in diabetic rats was analyzed. Increasing concentration of AGEs stimulation was associated with increased RASMC proliferation and increased ROS formation and they were decreased with statin in a dose-dependent manner. Increased NF-kappaB p65, phosphorylated ERK, phosphorylated p38 MAPK, cyclooxygenase-2, and c-jun by AGEs stimulation were noted and their expression was inhibited by statin. Neointimal formation after balloon injury was much thicker in diabetic rats than the sham-treated group but less neointimal growth was observed in those treated with statin after balloon injury. Increased ROS formation, subsequent activation of MAPK system and increased VSMC proliferation may be possible mechanisms of diabetic vasculopathy induced by AGEs and statin may play a key role in the treatment of AGEs-induced diabetic atherosclerosis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055082967

Download citation: RISBibTeXText

PMID: 19641377

DOI: 10.3858/emm.2009.41.11.086

Related references

Possible role of HMG CoA reductase inhibitor on the oxidative stress induced by advanced glycation endproducts(AGEs) in vascular smooth muscle cell(VSMC) of diabetic vasculopathy. 2007

W13-P-026 The potential role of advanced glycation end products (Ages) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy. Atherosclerosis Suppl.s 6(1): 91-92, 2005

Diabetic erythrocytes bearing cell surface advanced glycation endproducts interact with the receptor for advanced glycation endproducts to induce oxidant stress in endothelium and increase vascular permeability. Circulation 90(4 Part 2): I576, 1994

Advanced glycation endproducts interacting with their receptors activate vascular smooth muscle cells Induction of chemoattractants for smooth muscle cells and monocytes. Circulation 90(4 Part 2): I291, 1994

Advanced glycation endproducts induce a proliferative response in vascular smooth muscle cells via altered calcium signaling. Biochemical Pharmacology 76(9): 1110-1120, 2008

Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochemical and Biophysical Research Communications 239(1): 111-115, 1997

KCa3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells. Laboratory Investigation 93(2): 159-167, 2013

Selective increase in decorin core mRNA level in cultured vascular smooth muscle cells after exposure to advanced glycation endproducts. Journal of Health Science 46(3): 223-227, 2000

Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Experimental and Molecular Medicine 40(4): 398-406, 2008

Metformin reverts the oxidative stress and apoptosis induced by ages (advanced glycation endproducts) on osteoblastic cells. Bone 41(6): 0, 2007

Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 124(2): 263-269, 2009

Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Molecular and Cellular Biochemistry 335(1-2): 137-146, 2010

Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells. Journal of Genetics and Genomics 38(5): 193-200, 2012

Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. Journal of Nippon Medical School 68(6): 472-481, 2001

The role of autophagy in advanced glycation end product-induced proliferation and migration in rat vascular smooth muscle cells. Iranian Journal of Basic Medical Sciences 21(6): 634-638, 2018